ArticleDiagnostic pathology2013

P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas.

Dinka Sundov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.